17β-ESTRADIOL INHIBITS HEPATIC iNOS VIA THE ACTIVATION OF THE ESTROGEN RECEPTOR ER-α AND INHIBITION OF ERK1/2-miR-221 AXIS

Authors:

  • 1 November 2018
    • journal article
    • research article
    • Vol. 32  (6) , 1369-1377
    • PMID:30574741
Abstract
17 beta-Estradiol (E2) is known to negatively regulate inducible nitric oxide (NO) synthase (iNOS) expression via estrogen receptor alpha (ER-alpha) activation in aortic vascular smooth muscle cells. Therefore, we sought to determine whether E2 can inhibit iNOS in vivo in hepatic tissue via the activation of ER-alpha and whether extracellular signal-regulated kinases 1/2 (ERK1/2)-miR-221 axis is involved in this process. Male Wistar rats were treated with a bolus injection of E2 intraperitoneally (40 mu g/kg), and 24 hours after treatment the animals were sacrificed and the livers excised. The protein levels of iNOS, p50 and p65 subunits of nuclear factor kB (NFkB), ER alpha, ERK1/2 and protein kinase B (Akt), as well as the association of ER alpha/Src in liver lysates were assessed by Western blot. The expression of hepatic miR-221 was analyzed by qRT-PCR. Results show that E2 reduced hepatic iNOS protein expression (p < 0.01), the protein level of ER alpha (p < 0.05), ERK1/2 (p < 0.05), Akt phosphorylation (p < 0.001) and miR221 expression (p<0.05). In contrast, hepatic ER alpha/Src kinase association level (p < 0.05) increased after E2 treatment. Our results indicate that E2 inhibits hepatic iNOS via molecular mechanisms involving the activation of the ER-alpha and inhibition of ERK1/2-miR-221 axis.